Healthcare Sales & Marketing Network News: Barr Laboratories

Searching News Database: Barr Laboratories

HSMN NewsFeed - 30 Mar 2022
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Oct 2021
Tris Pharma(R) Hires Seasoned Business Development Executive
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 18 Apr 2017
Matinas BioPharma Appoints Dominick DiPaolo as Senior Vice President of Quality and Regulatory Compliance
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2014
Lannett Names Michael Bogda as President
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 13 Aug 2012
Teva Receives FDA Acceptance of Its New Drug Application for Quartette(TM) (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for the Prevention of Pregnancy
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Apr 2010
Penwest and Endo Enter Into Agreement With Barr to Settle Patent Litigation Over Opana(R) ER
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 28 Oct 2009
Watson and Barr Settle Lawsuit Over Oxytrol(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 3 Aug 2009
Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 Jul 2009
Mylan Announces Enhancements to Executive Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Mar 2009
Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 9 Feb 2009
Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
Biopharmaceuticals Generics

HSMN NewsFeed - 5 Jan 2009
Impax Appoints Christopher Mengler, R. PH., President of Global Pharmaceuticals Division
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Nov 2008
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 27 Oct 2008
FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Aug 2008
Barr Announces Approval of Generic Aredia(R) Injection, 30mg/mL, 60mg/mL and 90mg/mL Injectable
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 Jul 2008
Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 18 Jul 2008
Teva to Acquire Barr
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jun 2008
Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
Biopharmaceuticals Generics Licensing

HSMN NewsFeed - 1 May 2008
Sepracor Announces Final Settlement of XOPENEX(R) Inhalation Solution Patent Infringement Litigation with Breath Limited
Biopharmaceuticals Licensing

HSMN NewsFeed - 28 Mar 2008
Barr Announces Reorganization of Senior Management, Business Functions
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Mar 2008
Barr Receives Approval for Generic Taxol(R) Injection USP, 6mg/mL
Biopharmaceuticals Generics Oncology FDA

HSMN NewsFeed - 5 Mar 2008
Barr Subsidiary Sues Watson for SEASONIQUE(R) Patent Infringement
Biopharmaceuticals Litigation

HSMN NewsFeed - 3 Mar 2008
Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge
Biopharmaceuticals Litigation

HSMN NewsFeed - 19 Feb 2008
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 6 Feb 2008
Barr Launches Generic Fosamax(R) Tablets, 70 mg
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 11 Jan 2008
Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg
Biopharmaceuticals Generics

HSMN NewsFeed - 9 Jan 2008
Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL
Biopharmaceuticals Generics

HSMN NewsFeed - 2 Jan 2008
Barr Confirms Patent Challenge of Argatroban(R)
Biopharmaceuticals Litigation

HSMN NewsFeed - 2 Jan 2008
Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 28 Dec 2007
Encysive Pharmaceuticals Announces Patent Infringement Lawsuit Against Barr Laboratories
Biopharmaceuticals Litigation

HSMN NewsFeed - 14 Dec 2007
Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 Nov 2007
Amneal Receives FDA Approval for Bethanechol Chloride Tablets, USP Using New Expedited FDA Approval Process
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 20 Nov 2007
Barr Confirms Patent Challenge of Focalin(R) XR
Biopharmaceuticals Generics

HSMN NewsFeed - 30 Oct 2007
Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Oct 2007
Barr's Generic Version of Estrostep(R) Fe Tablets Approved
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 15 Oct 2007
Barr and Par Settle Diazepam Rectal Gel Patent Challenge with Valeant
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 2 Oct 2007
Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2007
Barr Confirms Patent Challenge of UROXATRAL(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 24 Sep 2007
Warner Chilcott Files Lawsuit Against Barr Laboratories, Inc. for Infringement of FEMCON FE Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 15 Aug 2007
Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
Biopharmaceuticals Generics

HSMN NewsFeed - 2 Aug 2007
Barr Announces Departure of President and COO; CEO Downey to Assume Responsibilities
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jul 2007
Barr Confirms Patent Challenge of TEMODAR(R)
Biopharmaceuticals Generics

HSMN NewsFeed - 16 Jul 2007
Barr Confirms Patent Challenge of Xopenex(R) Inhalation Solution, 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 12 Jul 2007
Barr Confirms Patent Challenge of Aggrenox(R)
Biopharmaceuticals Generics

HSMN NewsFeed - 9 Jul 2007
Barr Announces Approval of Generic Dostinex(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 5 Jul 2007
Women's Menstrual Cycles Can Be Seasonal with SEASONALE(TM): First Extended-Cycle Oral Contraceptive Approved by Health Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Jun 2007
Barr Announces Tentative Approval for a Generic Version of Effexor(R) Tablets, 25mg, 37.5mg, 50mg, 75mg and 100mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 25 Jun 2007
U.S. Supreme Court Denies Review of Tamoxifen Citrate Antitrust Lawsuits
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 22 Jun 2007
Barr Receives Approval for Generic VESANOID(R) Capsules, 10 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 5 Jun 2007
Barr Announces Tentative Approval for a Generic Version of Risperdal(R) Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 4 Jun 2007
Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac(R) Weekly(TM)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 11 May 2007
Barr Receives Tentative Approval for a Generic Version of Razadyne(R) Tablets, 4mg, 8mg and 12mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 2 May 2007
Barr Receives Approval for Generic Nimotop(R) Capsules, 30 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 30 Apr 2007
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Apr 2007
Barr Confirms Patent Challenge of Ambien CR(R)
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 20 Mar 2007
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
Biopharmaceuticals Generics

HSMN NewsFeed - 6 Feb 2007
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 30 Jan 2007
Barr Launches Generic PROSCAR(R) Tablets, 5 mg
Biopharmaceuticals Generics

HSMN NewsFeed - 23 Jan 2007
Barr Confirms Generic Thalomid(R) Suit Filed
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 23 Jan 2007
Barr's Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 19 Jan 2007
Barr Launches Generic METAGLIP(TM) Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg
Biopharmaceuticals Generics Endocrinology

HSMN NewsFeed - 18 Jan 2007
Barr Receives Tentative Approval for Generic KYTRIL(R) Tablets, 1mg (Base)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Dec 2006
Barr Confirms Generic Thalomid(R) Capsule, 50 mg and 100 mg Application
Biopharmaceuticals Generics Oncology FDA

HSMN NewsFeed - 13 Dec 2006
Barr Confirms Generic Thalomid(R) Capsule Application
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 4 Dec 2006
Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 28 Nov 2006
Barr's Subsidiary PLIVA Receives Approval for Pravastatin Tablets 10mg, 20mg, and 40mg and Tentative Approval for 80mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 9 Nov 2006
Barr Receives Tentative Approval for a Generic Version of ZYPREXA(R) Zydis(R) Tablets, 5mg, 10mg, 15mg and 20mg
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 6 Nov 2006
Barr Launches Plan B(R) OTC/Rx Dual-Label Product; Awarded 3 Years New Product Exclusivity
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Oct 2006
Barr Acquires PLIVA d.d. Following Official Closing of Tender Offer Process
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 28 Sep 2006
Barr Cleared to Launch ADDERALL(R) IR
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 27 Sep 2006
Barr Launches Generic ACTIQ(R) Cancer Pain Management Product
Biopharmaceuticals Generics Drug Delivery

HSMN NewsFeed - 26 Sep 2006
Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Barr Laboratories Inc.
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 26 Sep 2006
Barr Announces Warner Chilcott Waives Exclusive License for OVCON(R) 35
Biopharmaceuticals Generics

HSMN NewsFeed - 18 Sep 2006
U.S. Court of Appeals Denies Rehearing Request in Dismissal of Tamoxifen Citrate Antitrust Lawsuits
Biopharmaceuticals Oncology Generics Litigation

HSMN NewsFeed - 7 Sep 2006
Barr Launches a Generic Version of its SEASONALE(R) Extended-Cycle Oral Contraceptive
Biopharmaceuticals Generics

HSMN NewsFeed - 6 Jul 2006
Barr Confirms Patent Challenge of Razadyne(R) ER Capsules
Biopharmaceuticals Litigation

HSMN NewsFeed - 29 Jun 2006
Cephalon Receives Approvable Letter for FENTORA(TM) (fentanyl buccal tablet) for Management of Breakthrough Pain in Patients with Cancer
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 25 May 2006
FDA Approves Duramed's SEASONIQUE(TM) Extended-Cycle Oral Contraceptive Company's Second Proprietary Extended-Cycle OC to be Available in July

HSMN NewsFeed - 12 May 2006
Barr Receives Approval for Isotretinoin Capsules USP, 30 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 12 May 2006
Barr Confirms Non-Final Rejection Notice From Patent and Trademark Office on Duramed's Reissue Application for SEASONALE(R) '032 Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 11 May 2006
Barr Challenging Patents Protecting Prozac(R) Weekly(TM)
Biopharmaceuticals Generics Litigation

Return to NewsFeed

Additional items found! 128

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 128 additional stories matching:
Barr Laboratories
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.